ENSG vs NEOG: fair value comparison
The Ensign Group, Inc. and Neogen Corporation · Updated 2026-10-19
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, ENSG currently sits closer to the top of our ranking by discount to fair value.
| ENSG | NEOG | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $176.63 | $11.81 |
| 12-month range | $147.13–$215.83 | $5.41–$13.98 |
| Rank by discount to fair value | #44 of 108 Healthcare | #103 of 108 Healthcare |
| Quality grade | D | D |
| Leverage | Moderate | Low |
| Margin trend | Contracting | Expanding |
| Revenue growth | Strong | Declining |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Mixed |
| DCF cross-check | Overvalued | — |
| 52-week position | The lower-middle quarter | The upper-middle quarter |
Full single-stock breakdowns: ENSG fair value analysis · NEOG fair value analysis